Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis
This study has been completed.
Study NCT00556075   Information provided by Repros Therapeutics Inc.
First Received: November 7, 2007   Last Updated: August 11, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Endometriosis
More general conditions related to this trial
Genital Diseases, Female
Interventions listed in this trial
Proellex 25 mg
Placebo
Proellex 50 mg
Sponsors listed in this trial
Repros Therapeutics Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services